Cannabis Investing Network · CIN Podcast

#217 - Should Investors Buy Cannabis Stocks in 2026 ? (ft. Charting Man Dan of The Chart Guys)

January 15, 2026·1 hr 23 min·5 clips
Dan calls cannabis “the most disappointing sector” and says it sits at the bottom with altcoins.
1. Cannabis Investing Network #217 focuses on whether cannabis stocks deserve investor money in 2026 after a “roller coaster 2025.” 2. Manish hosts the episode, and Chartman Dan of The Chart Guys returns as the technical trader whose read on momentum matters for cannabis. 3. The episode asks whether cannabis is attractive now, how Schedule 3 could change the setup, and how cannabis compares with AI, semiconductors, and other sectors. 4. Dan says the first week of 2026 showed “significant divergence” between MAG7 big tech and semiconductors, while capital rotated into robotics, drones, and quantum. 5. He describes his style as “wait and see and react,” and says he is watching for actual signs before committing to cannabis. 6. Dan says he was “playing the momentum” around the late-2025 executive-order sequence, but also trimmed size in MSOS at seven because a “sell the news reaction” was possible. 7. Manish argues that cannabis is still federally illegal and that state-level fundamentals in places like Florida, Illinois, and New Jersey remain under pressure. 8. He says cannabis revenues were often flat or down in 2025 even as companies operated more stores, which he treats as a bad trend. 9. Dan agrees that the sector is disappointing for valid reasons and says he is not assuming it will recover without clear changes in price action and volume. 10. Manish walks through opportunity cost, comparing cannabis returns against the S&P 500 and against stocks that have a much wider margin of safety. 11. He says Schedule 3 could still create a “double from today’s level” within 60 to 90 days, but also frames a possible 50% downside as part of the trade-off. 12. Dan says his 2025 swing trading beat the S&P 500 and that his risk-on account was up “60 something percent,” helped mostly by psychedelics. 13. He names ATAI as a major psychedelic winner and says that sector showed a steady uptrend of higher lows and higher highs without needing constant news. 14. Dan contrasts that with cannabis, which he says often needs a headline to spike higher before grinding back down. 15. He says cannabis has already gone through “at least four distinct pump and dump cycles” over 15 years of trading. 16. Manish then explains that fundamental investors still end up using numbers “on a screen,” multiples, and earnings trends, even without deep business specialization. 17. Dan agrees that a stock’s valuation depends heavily on whether earnings are accelerating or decelerating, not only on whether the numbers are positive. 18. The tone stays analytical and candid, with Manish pressing valuation questions and Dan answering from a technical, momentum-driven perspective. 19. Traders and cannabis investors who want a blunt 2026 setup read should listen. 20. People wanting a long-form sector cheerleading session should probably skip it.

As heard by us

A sober valuation debate on whether cannabis stocks are cheap, broken, or both.

The episode takes a clear look at a hard question: whether cannabis still offers a real investment case in 2026 after a rough 2025. It stays grounded in valuation discipline, with Manish and Chartman Dan walking through earnings growth, P/E multiples, PEG ratios, and how market…

Read the full review in PlayNext →

Why you'd press play

You want a measured 2026 cannabis investing conversation, not a hype cycle.

Read the full recommendation in PlayNext →
Listen to the show on